Global Swine Healthcare Market Growth (Status and Outlook) 2023-2029
Swine health is associated with the diseases caused due to pigs and the development of therapeutics to prevent the related ailments and disorders. Pig breeding can lead to many diseases such as reproductive disease and congenital malformations. Hence, governmental organizations are launching programs to protect and enhance the health of swine, which reduces the effect of swine diseases on humans.
LPI (LP Information)' newest research report, the “Swine Healthcare Industry Forecast” looks at past sales and reviews total world Swine Healthcare sales in 2022, providing a comprehensive analysis by region and market sector of projected Swine Healthcare sales for 2023 through 2029. With Swine Healthcare sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Swine Healthcare industry.
This Insight Report provides a comprehensive analysis of the global Swine Healthcare landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Swine Healthcare portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Swine Healthcare market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Swine Healthcare and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Swine Healthcare.
The global Swine Healthcare market size is projected to grow from US$ 1831 million in 2022 to US$ 2519.9 million in 2029; it is expected to grow at a CAGR of 4.7% from 2023 to 2029.
The increasing demand for livestock products on a global level will drive the growth prospects for the global swine health market during the predicted period. The adoption rate of antibiotics, vaccines, and other treatments is anticipated to grow with the increasing number of initiatives taken by government and vendors to prevent any zoonotic disease from affecting livestock production. Since the production of quality livestock products is dependent on the health of the animal, many vendors are increasingly adopting more number of drugs to prevent and treat diseases of swine. The above two factors will boost the demand for drugs, antibiotics, and vaccines, which, in turn, will propel the rate of revenue generation in the market.
This report presents a comprehensive overview, market shares, and growth opportunities of Swine Healthcare market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Vaccines
Parasiticides
Anti-Infectives
Medicinal Feed Additives
Others
Segmentation by application
Farm
House
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Zoetis
Merck
Elanco (Eli Lilly)
Boehringer Ingelheim
Ceva Sante Animale
Vetoquinol
Please note: The report will take approximately 2 business days to prepare and deliver.